FGAM
CVAC

Financial Gravity Asset Management’s CureVac CVAC Stock Holding History

Financial Gravity Asset Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10
Closed -$19 – 1361
2023
Q2 		$19 Buy
+10
New +$89 ﹤0.01% 1493
2023
Q1 		– Sell
-6
Closed -$11 – 1260
2022
Q4 		$11 Buy
+6
New +$44 ﹤0.01% 1360

Other funds holding CVAC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Financial Gravity Asset Management's CVAC Position: Q3 2023 in Review

Financial Gravity Asset Management sold out of CureVac (CVAC) in Q3 2023, closing a stake of 10 shares — an estimated $19 sold.

Financial Gravity Asset Management first reported a position in CVAC in Q4 2022 and held it in 2 quarters. The position peaked at $19 in Q2 2023. 84 funds tracked by Wall St. Rank hold CVAC as of Q3 2023.

  • Financial Gravity Asset Management reported no remaining CureVac position as of Q3 2023 after selling out during the quarter.
  • Financial Gravity Asset Management sold 10 CureVac shares in Q3 2023, an estimated $19.
  • Financial Gravity Asset Management first reported a position in CureVac in Q4 2022 and held it in 2 quarters.
  • Financial Gravity Asset Management's CureVac position peaked at $19 in Q2 2023.
  • 84 funds tracked by Wall St. Rank held CureVac as of Q3 2023.

Based on Financial Gravity Asset Management's 13F filing for Q3 2023, filed 16 Nov 2023.